0001209191-17-034536.txt : 20170522
0001209191-17-034536.hdr.sgml : 20170522
20170522215603
ACCESSION NUMBER: 0001209191-17-034536
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170227
FILED AS OF DATE: 20170522
DATE AS OF CHANGE: 20170522
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SECOND SIGHT MEDICAL PRODUCTS INC
CENTRAL INDEX KEY: 0001266806
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3
CITY: SYLMAR
STATE: CA
ZIP: 91342
BUSINESS PHONE: 818-833-5000
MAIL ADDRESS:
STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3
CITY: SYLMAR
STATE: CA
ZIP: 91342
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Incumed, LLC
CENTRAL INDEX KEY: 0001678708
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36747
FILM NUMBER: 17862557
BUSINESS ADDRESS:
STREET 1: 25134 RYE CANYON LOOP
STREET 2: SUITE 300
CITY: VALENCIA
STATE: CA
ZIP: 91355
BUSINESS PHONE: 213-683-8790
MAIL ADDRESS:
STREET 1: 25134 RYE CANYON LOOP
STREET 2: SUITE 300
CITY: VALENCIA
STATE: CA
ZIP: 91355
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alfred E. Mann Living Trust
CENTRAL INDEX KEY: 0001678706
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36747
FILM NUMBER: 17862558
BUSINESS ADDRESS:
STREET 1: 25134 RYE CANYON LOOP
STREET 2: SUITE 300
CITY: VALENCIA
STATE: CA
ZIP: 91355
BUSINESS PHONE: 213-683-8790
MAIL ADDRESS:
STREET 1: 25134 RYE CANYON LOOP
STREET 2: SUITE 300
CITY: VALENCIA
STATE: CA
ZIP: 91355
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-02-27
1
0001266806
SECOND SIGHT MEDICAL PRODUCTS INC
EYES
0001678706
Alfred E. Mann Living Trust
12744 SAN FERNANDO ROAD
SYLMAR
CA
91342
0
0
1
0
0001678708
Incumed, LLC
12744 SAN FERNANDO ROAD
SYLMAR
CA
91342
0
0
1
0
Common Stock
2017-02-27
4
S
0
40591
1.675
D
2226145
I
By Incumed, LLC
Common Stock
2017-02-28
4
S
0
39028
1.6492
D
2187117
I
By Incumed, LLC
Common Stock
2017-03-01
4
S
0
44126
1.6175
D
2142991
I
By Incumed, LLC
Common Stock
2017-03-02
4
S
0
55824
1.5328
D
2087167
I
By Incumed, LLC
Common Stock
2017-03-03
4
S
0
21715
1.5258
D
2065452
I
By Incumed, LLC
Common Stock
2017-03-06
4
S
0
113359
1.4305
D
1952093
I
By Incumed, LLC
Common Stock
2017-03-07
4
S
0
94084
1.4784
D
1858009
I
By Incumed, LLC
Common Stock
2017-03-08
4
S
0
182917
1.6869
D
1675092
I
By Incumed, LLC
Common Stock
2017-03-09
4
S
0
105865
1.5714
D
1569227
I
By Incumed, LLC
Common Stock
2017-03-10
4
S
0
118740
1.3841
D
1450487
I
By Incumed, LLC
Common Stock
2017-03-13
4
S
0
23916
1.3798
D
1426571
I
By Incumed, LLC
Common Stock
2017-04-07
4
S
0
1426571
1.00
D
0
I
By Incumed, LLC
Common Stock
2017-04-07
4
S
0
5218420
1.00
D
0
D
Warrants to Purchase Common Stock
5.00
2017-04-07
4
S
0
80000
0.001
D
2012-07-31
2017-07-31
Common Stock
80000
0
D
Warrants to Purchase Common Stock
5.00
2017-04-07
4
S
0
280000
0.001
D
2013-02-23
2018-02-28
Common Stock
280000
0
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.61 to $1.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.59 to $1.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.50 to $1.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.51 to $1.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.38 to $1.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.40 to $1.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.48 to $1.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.32 to $1.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.35 to $1.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Private sale to group of individual accredited private investors.
Shares disposed of by the reporting persons during the one year period following the death of Alfred E. Mann were exempt from reporting in compliance with Rule 16(a)(2)(d) of the Securities Exchange Act of 1934, as amended.
/s/ Anoosheh Bostani and /s/ Michael S. Dreyer, Trustees of the Alfred E. Mann Living Trust
2017-05-22
/s/ Anoosheh Bostani and /s/ Michael S. Dreyer, Trustees of the Alfred E. Mann Living Trust, the Manager of Incumed LLC
2017-05-22